Page results
-
Acute loss of sense of smell should be considered globally as a criterion for self-isolation, testing, and contact tracing for Covid-19 infection according to researchers at UCLH and UCL.
-
This page is for patients who have been referred by their GP to a gynaecology specialist because their symptoms need further tests.
-
A research team involving UCLH clinicians has found a way to reduce the side effects of treatment for a disorder of the adrenal glands.
-
UCLH NHS Foundation Trust has once again formed a partnership with the Business Design Centre in Islington to reopen a large-scale COVID-19 vaccination centre on site from Saturday 18 December.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
This page is for patients who have been referred on a suspected cancer pathway.
-
This page has been written for parents, carers and family members who are acting as carers and comforters for children and young people having radioactive mIBG treatment.
File results
-
FOI/2023/0948 - Inpatient wards and bed capacity
-
FOI/2023/0954 - Treatment of melanoma/ Renal cell carcinoma/ Oesophageal cancer
-
FOI/2023/0957 - Maternity services intervention statistics; still birth, elective C-section, emergency C-section
-
FOI/2023/0961 - Robotic Process Automation staff details
-
FOI/2024/0001 - Intrathecal therapy services/ spasticity service
-
FOI/2024/0003 - Translation, interpretation and language service costs - 2019/20 to 2022/2023
-
FOI/2024/0009 - Electronic Patient Record (EPR) and Medical Device Integration (MDI) solution
-
FOI/2024/0012 - Paediatric asthma wait time and referrals
-
FOI/2024/0013 - Medications within dermatology and respiratory medicine
-
FOI/2024/0017 - Assault attendances to Emergency Department 2023